Cell and Gene Commercialization
-
Creating A Sustainable Business Model For Cell And Gene Therapies
10/5/2023
Avoid product launch delays and expand patient access to CGTs by understanding and meeting regulatory guidelines and securing approval for reimbursement of treatment costs.
-
The New Economics Of Cell And Gene Therapy
10/5/2023
The authors explain why we are seeing more withdrawals than blockbusters and what we should do about it.
-
The Role Of Allogeneic Treatments In The Future Of Cell Therapy
10/4/2023
Review considerations for a successful development and manufacturing process and learn how finding an experienced partner can help you overcome hurdles on the path to IND.
-
Future Challenges And Predictions For CGT Patient-Focused Solutions
10/4/2023
Leveraging innovative technologies to predict, model, and analyze data will enhance resource allocation, improve patient experience, reduce timelines, and drive cost efficiencies in the CGT industry.
-
3 Questions To Ask When Building A CGT Commercialization Strategy
10/3/2023
Learn how aligning with the right partner and leveraging integrated solutions gives access to crucial know-how and ensures the patient receives the most seamless, accessible treatment option available.
-
Charting The Landscape Of Cell & Gene Therapy Reimbursement In The U.S.
10/3/2023
While the science of cell and gene therapies is transformative, our U.S. healthcare system’s reimbursement infrastructure has some catching up to do. This article explores the current dynamics and landscape of carve-out policies, spotlighting Massachusetts' actions for sickle cell disease patients as a notable example driving equity in care.
-
Part 2: Getting The System Ready: Enabling Investment In Community Hospitals To Improve Patient Access To Cell And Gene Therapies
10/3/2023
In part two of their two-part series, the authors detail why enabling community hospitals to alleviate system constraints would usher a change in the future of CGT therapy delivery.
-
Part 1: Mobilizing Community Hospitals To Improve Patient Access To Cell And Gene Therapies
10/2/2023
In part one of a two-part series, the authors discuss the need to address several key issues in the expansion of cell and gene therapies into community hospitals.
-
3 Opportunities And 3 Challenges In The Cell And Gene Therapy Market
10/2/2023
Learn how an end-to-end commercialization service experienced in bringing CGTs to market can help avoid potential obstacles and ensure your commercialization strategy is optimized from the early stages.
-
CGT Solutions Brochure
9/30/2023
Leveraging a partner with expertise and integrated, end-to-end solutions can help overcome obstacles to increase patient access and ensure the safe distribution of your advanced therapy product.